Sari Tuupanen is the Director of Genetics in the Clinical Interpretation (CI) team at Blueprint Genetics. She works closely with other CI directors, associate laboratory directors, and managers, and leads in maintaining and developing high-quality clinical interpretation processes, reporting policies, and interpretation tools. She oversees the CI process and supports the sign-out team to ensure high-quality clinical reports. She has an MSc in human genetics and received her PhD in cancer genetics from the University of Helsinki in 2009. She has experience in working with both research and clinical laboratories. She joined Blueprint Genetics in 2015 to work as a geneticist. She has extensive knowledge in both panel (primary focus ophthalmology) and exome interpretation and in her previous position she worked as a team manager in the Opthalmology Interpretation Team.